This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Main Inclusion/Exlusion:
- Completed all planned cancer-directed surgery
- Patients must be taking a once daily endocrine therapy drug initiated within the 6 months prior to registration OR have received a prescription for a once daily ET medication with stated intent to initiate within 6 weeks after registration.
- No history of previous cancer
Indications:
- stage I-III, hormone receptor positive, HER2-neu negative, invasive breast cancer
Contact: cajwciclinicaltrials@providence.org